Tolerance and Pharmacokinetics of SHR1459 in Patients With Recurrent Replased/Refractory Mature B Cell Neoplasmstumor
Clinical trial NCT03664297 · UNKNOWN
Trial details
- NCT number
- NCT03664297
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-06
- Primary completion
- 2023-12-30
- Enrollment
- 86
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.